4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203

News   Jan 22, 2010

 
 4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203
 
 
 

RELATED ARTICLES

Gene Therapy Improves Heart Function by up to 25%

News

Intracoronary delivery of the gene vector was safe and improved heart function in a large animal model.

READ MORE

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

How do Poison Frogs Protect Themselves Against Their Own Neurotoxin?

News

Scientists are a step closer to resolving a related head-scratcher, how do these frogs keep from poisoning themselves?

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE